38.5
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood…
The tumor microenvironment comprises the tumor and the supporting tissue surrounding it, also known as the stroma. Tumor cells constantly interact with the stroma to form a permissive and supportive environment for their growth and metastasis.
The stroma consists of an extracellular matrix that surrounds the tumor and several cellular components.
The Extracellular Matrix, or ECM, is a complex network of macromolecules, including collagen and fibrin. Compared to normal tissues, the structure and composition of ECM in cancerous tissue are modified to promote tumor progression.
For example, in breast cancer tissue, the increased expression of protease and oxidases degrade and linearize the dense network of cross-linked collagen fibers. This increases the stiffness of breast cancer tissue facilitating tumor cell migration.
The stroma also consists of Carcinoma-Associated Fibroblasts, or CAFs. They secrete several growth factors to aid cancer progression. For example, with the increase in tumor size, the demand for nutrients and oxygen increases. The innermost cancer cells in a solid tumor face acute oxygen limitation; a phenomenon called hypoxia.
CAFs secrete vascular endothelial growth factors that trigger the formation of new blood vessels around the growing tumor. This provides oxygen and nutrients to the rapidly dividing cells.
The immune cells, such as macrophages, lymphocytes, and natural killer cells, can detect the cancer cells and eliminate them. However, due to the increased genetic instability, cancer cells quickly acquire mutations to evade immune surveillance.
For example, tumor cells can induce immunosuppressive T-cells, which produce reactive oxygen species to inhibit the lymphocytes and prevent them from killing the tumor cells. The reactive oxygen species also increase the rate of mutations in tumor cells, facilitating rapid tumor progression.
View the full transcript and gain access to JoVE Core videos
Q1: What is the tumor microenvironment and why does it matter in cancer?
The tumor microenvironment (TME) is the complex tissue surrounding cancer cells, including immune cells, fibroblasts, blood vessels, and extracellular matrix components. It plays a critical role in tumor progression, influencing how cancer cells grow, survive, and spread. Understanding the TME is essential for developing effective cancer therapies that target both tumor cells and their supporting tissue.
Q2: What cellular components make up the tumor microenvironment?
The tumor microenvironment contains stromal cells like fibroblasts, immune cells including T cells and macrophages, endothelial cells forming blood vessels, and the extracellular matrix. These components work together to create a specialized tissue environment. The specific composition varies depending on cancer type and stage, influencing tumor behavior and treatment response.
Q3: How does the immune response function within the tumor microenvironment?
The immune response in the tumor microenvironment involves T cells, macrophages, and other immune cells attempting to recognize and eliminate cancer cells. However, tumors often evade this immune response through various mechanisms, creating an immunosuppressive environment. This immune evasion is a hallmark of cancer progression and a major target for immunotherapy development.
Q4: What role does the extracellular matrix play in tumor development?
The extracellular matrix in the tumor microenvironment provides structural support and contains signaling molecules that influence cancer cell behavior. It acts as a physical barrier that can either restrict or facilitate tumor growth and metastasis. Matrix remodeling by stromal cells creates pathways for cancer cells to invade surrounding tissues and enter the bloodstream.
Q5: How do stromal cells contribute to tumor progression?
Stromal cells, primarily fibroblasts, actively support tumor progression by secreting growth factors, remodeling the extracellular matrix, and promoting angiogenesis. These cells can become activated by tumor signals and adopt a cancer-associated phenotype. Their interactions with cancer cells create a permissive environment that accelerates tumor growth and therapeutic resistance.
Q6: Why is the tumor microenvironment important for cancer metastasis?
The tumor microenvironment facilitates metastasis by promoting epithelial-mesenchymal transition, creating pathways through the extracellular matrix, and suppressing immune surveillance. Remodeled stromal tissue enables cancer cells to invade blood vessels and survive in circulation. Understanding these microenvironmental changes is crucial for developing strategies to prevent cancer spread to distant organs.
Q7: How can targeting the tumor microenvironment improve cancer treatment?
Therapeutic targeting of the tumor microenvironment involves strategies such as blocking stromal cell activation, remodeling the extracellular matrix, promoting immune response, and normalizing blood vessels. These approaches can reduce tumor support systems and enhance the effectiveness of conventional therapies. Combination treatments targeting both cancer cells and their microenvironment show promise in overcoming therapeutic resistance.